About A/Prof Daniel van Langenberg
Dr van Langenberg is a consultant gastroenterologist in private practice in Melbourne's Eastern suburbs and has public hospital appointments as Director of IBD, Eastern Health and Senior Lecturer at M ...
Special interests
Qualifications
MBBS (Monash 2001)
PhD (Monash 2012)
FRACP 2009
Awards and Publications
- Young Investigator Award (Douglas Piper award for best presentation in clinical research), Australian Gastroenterology Week 2011
- Paper of Distinction Award, Aust. Gastroenterology Week 2011 & 2012
- Finalist, Eastern Health Research Week 2011
- Finalist, Royal Adelaide Hospital NIMMO award 2008
- Poster of Merit Award, Aust. Gastroenterology Week 2010
- Recipient of Abbott IBD clinical research grant 2011
- Recipient of Ferring Travelling Fellowship 2011
- Recipient of NHMRC Postgraduate Research Scholarship 2010-2012
- Recipient of GESA travel grant 2010
Peer reviewed publications:
- DR van Langenberg, RB Gearry, M Ward, HL Wong, PR Gibson. The role of faecal lactoferrin in the evaluation of hospitalised patients with diarrhoea. Intern Med J 2010 Dec;40(12):819-27.
- JM Andrews, RE Mountfield, DR van Langenberg, PA Bampton, GJ Holtmann. Review: Unpromoted issues in inflammatory bowel disease (IBD) – opportunities to optimize care. Intern Med J 2010; 40: 173–182.
- NY Zakary, DR van Langenberg, M Alshumrany, MN Schoeman. Acute haemorrhage from a Dieulafoy lesion within a gastric diverticulum managed endoscopically J Gastroenterol Hepatol. 2009 Dec;24(12):1891.
- DR van Langenberg, SJ Simon, G Holtmann, JM Andrews. The burden of inpatient costs in inflammatory bowel disease: opportunities to optimize care. J Crohn Colitis 2010 Oct;4(4):413-21.
- DR van Langenberg, K Lange, DJ Hetzel, G Holtmann, JM Andrews. Adverse clinical phenotype in IBD: a cross sectional study identifying factors potentially amenable to change. J Gastroenterol Hepatol. 2010 Jul;25(7):1250-8.
- DR van Langenberg, PR Gibson. Systematic Review: Fatigue in inflammatory bowel disease. Aliment Pharm Ther 2010; 32 (2): 131–143.
- RV Bryant, DR van Langenberg, GJ Holtmann, JM Andrews. Functional gastrointestinal disorders in IBD patients: functional symptoms correlate with poorer health-related quality of life and increased psychological co-morbidity. J Gastroenterol Hepatol. 2011 May;26(5):916-23.
- JM Andrews, RV Bryant, DR van Langenberg, GJ Holtmann. Are all symptoms in patients with IBD due to occult inflammation? Am J Gastroenterol 2010;105(12): 2703.
- J. Gapasin, DR van Langenberg, G Holtmann, DJ Hetzel, JM Andrews. Potentially avoidable surgery in IBD: what proportion of patients come to resection without optimal preoperative therapy? A guidelines-based audit. Intern Med J 2012; 42(5):e84-88
- DR van Langenberg, G Morrison, A Foley, RJ Buttigieg, PR Gibson. Cytomegalovirus disease, haemophagocytic syndrome, immunosuppression in patients with IBD: ‘a cocktail best avoided, not stirred’. J Crohn Colitis April 2011; 5(5): 469-472
- C Sack, VA Phan, R Grafton, GJ Holtmann, DR van Langenberg, K Brett, M Clark, JM Andrews. A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease. J Crohn Colitis 2012; 6(3):302-310.
- DR van Langenberg, JM Andrews. Satisfaction with patient-doctor relationships in inflammatory bowel diseases: Examining patient-initiated change of specialist World J Gastroenterol 2012; 18(18): 2212-2218
- G Morrison, DR van Langenberg, SJ Gibson, PR Gibson. Chronic pain in inflammatory bowel disease: characteristics and associations in a hospital-based cohort. Inflamm Bowel Dis 2012 [submitted, under review]
- DR van Langenberg, P Della Gatta, B Hill, S A Warmington, D K Kidgell, PR Gibson, AP Russell. Identification of molecular factors regulating skeletal muscle mass and function in patients with Crohn’s disease. Clin Gastro Hepatol 2012